Seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) among healthcare providers prior to the vaccine era in an integrated midwestern healthcare system.
Antimicrob Steward Healthc Epidemiol
; 2(1): e47, 2022.
Article
in English
| MEDLINE | ID: covidwho-1860205
ABSTRACT
We performed severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antinucleocapsid IgG testing on 5,557 healthcare providers and found a seroprevalence of 3.9%. African Americans were more likely to test positive than Whites, and HCWs with household exposure and those working on COVID-19 cohorting units were more likely to test positive than their peers.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Cohort study
/
Observational study
/
Prognostic study
Topics:
Vaccines
Language:
English
Journal:
Antimicrob Steward Healthc Epidemiol
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS